Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today ...

Nuvation Bio Inc. (NYSE:NUVB) creates therapies and medications to diagnose, treat, and manage cancer. The company’s leading product is taletrectinib, which treats advanced ROS1-positive non ...

Nuvation Bio (NYSE:NUVB) raced as much as 8% on Friday after SEC filings showed that insiders in the company bought shares worth $1.1M in the week. This was the highest total value of shares ...

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the ...

Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer ...

Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer ...

View Nuvation Bio, Inc. Class A NUVB stock quote prices, financial information, real-time forecasts, and company news from CNN.

Nuvation Bio (NUVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Nuvation Bio Inc. (NYSE:NUVB) stands against the other best ...

Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer ...

Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer ...

Nuvation Bio Inc. (NUVB) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.